Selected research
Market Analysis & Forecast
Global Treatment of PNH Market Analysis and Forecast 2026-2032
Market perspective
The global Treatment of PNH market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Treatment of PNH is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Treatment of PNH is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Treatment of PNH is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Treatment of PNH is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Treatment of PNH include Alexion Pharmaceuticals, Apellis Pharmaceuticals, Samsung Bioepis, Amgen, Roche and Novartis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Treatment of PNH, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Treatment of PNH, also provides the sales of main regions and countries. Of the upcoming market potential for Treatment of PNH, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Treatment of PNH sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Treatment of PNH market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Treatment of PNH sales, projected growth trends, production technology, application and end-user industry.
Treatment of PNH Segment by Company
Alexion Pharmaceuticals
Apellis Pharmaceuticals
Samsung Bioepis
Amgen
Roche
Novartis
Treatment of PNH Segment by Type
Complement Inhibitors
Supportive Care
Others
Treatment of PNH Segment by Application
Hospital
Clinic
Other
Treatment of PNH Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Treatment of PNH market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Treatment of PNH and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Treatment of PNH.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Treatment of PNH in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Treatment of PNH manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Treatment of PNH sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Complement Inhibitors
- Supportive Care
- Others
Applications
- Hospital
- Clinic
- Other
Companies covered
- Alexion Pharmaceuticals
- Apellis Pharmaceuticals
- Samsung Bioepis
- Amgen
- Roche
- Novartis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Treatment of PNH Market by Type
- 1.2.1 Global Treatment of PNH Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Complement Inhibitors
- 1.2.3 Supportive Care
- 1.2.4 Others
- 1.3 Treatment of PNH Market by Application
- 1.3.1 Global Treatment of PNH Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Treatment of PNH Market Dynamics
- 2.1 Treatment of PNH Industry Trends
- 2.2 Treatment of PNH Industry Drivers
- 2.3 Treatment of PNH Industry Opportunities and Challenges
- 2.4 Treatment of PNH Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Treatment of PNH Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Treatment of PNH Revenue by Region
- 3.2.1 Global Treatment of PNH Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Treatment of PNH Revenue by Region (2021-2026)
- 3.2.3 Global Treatment of PNH Revenue by Region (2027-2032)
- 3.2.4 Global Treatment of PNH Revenue Market Share by Region (2021-2032)
- 3.3 Global Treatment of PNH Sales Estimates and Forecasts 2021-2032
- 3.4 Global Treatment of PNH Sales by Region
- 3.4.1 Global Treatment of PNH Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Treatment of PNH Sales by Region (2021-2026)
- 3.4.3 Global Treatment of PNH Sales by Region (2027-2032)
- 3.4.4 Global Treatment of PNH Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Treatment of PNH Revenue by Manufacturers
- 4.1.1 Global Treatment of PNH Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Treatment of PNH Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Treatment of PNH Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Treatment of PNH Sales by Manufacturers
- 4.2.1 Global Treatment of PNH Sales by Manufacturers (2021-2026)
- 4.2.2 Global Treatment of PNH Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Treatment of PNH Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Treatment of PNH Sales Price by Manufacturers (2021-2026)
- 4.4 Global Treatment of PNH Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Treatment of PNH Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Treatment of PNH Manufacturers, Product Type & Application
- 4.7 Global Treatment of PNH Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Treatment of PNH Market CR5 and HHI
- 4.8.2 2025 Treatment of PNH Tier 1, Tier 2, and Tier 3
5 Treatment of PNH Market by Type
- 5.1 Global Treatment of PNH Revenue by Type
- 5.1.1 Global Treatment of PNH Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Treatment of PNH Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Treatment of PNH Revenue Market Share by Type (2021-2032)
- 5.2 Global Treatment of PNH Sales by Type
- 5.2.1 Global Treatment of PNH Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Treatment of PNH Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Treatment of PNH Sales Market Share by Type (2021-2032)
- 5.3 Global Treatment of PNH Price by Type
6 Treatment of PNH Market by Application
- 6.1 Global Treatment of PNH Revenue by Application
- 6.1.1 Global Treatment of PNH Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Treatment of PNH Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Treatment of PNH Revenue Market Share by Application (2021-2032)
- 6.2 Global Treatment of PNH Sales by Application
- 6.2.1 Global Treatment of PNH Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Treatment of PNH Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Treatment of PNH Sales Market Share by Application (2021-2032)
- 6.3 Global Treatment of PNH Price by Application
7 Company Profiles
- 7.1 Alexion Pharmaceuticals
- 7.1.1 Alexion Pharmaceuticals Company Information
- 7.1.2 Alexion Pharmaceuticals Business Overview
- 7.1.3 Alexion Pharmaceuticals Treatment of PNH Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Alexion Pharmaceuticals Treatment of PNH Product Portfolio
- 7.1.5 Alexion Pharmaceuticals Recent Developments
- 7.2 Apellis Pharmaceuticals
- 7.2.1 Apellis Pharmaceuticals Company Information
- 7.2.2 Apellis Pharmaceuticals Business Overview
- 7.2.3 Apellis Pharmaceuticals Treatment of PNH Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Apellis Pharmaceuticals Treatment of PNH Product Portfolio
- 7.2.5 Apellis Pharmaceuticals Recent Developments
- 7.3 Samsung Bioepis
- 7.3.1 Samsung Bioepis Company Information
- 7.3.2 Samsung Bioepis Business Overview
- 7.3.3 Samsung Bioepis Treatment of PNH Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Samsung Bioepis Treatment of PNH Product Portfolio
- 7.3.5 Samsung Bioepis Recent Developments
- 7.4 Amgen
- 7.4.1 Amgen Company Information
- 7.4.2 Amgen Business Overview
- 7.4.3 Amgen Treatment of PNH Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Amgen Treatment of PNH Product Portfolio
- 7.4.5 Amgen Recent Developments
- 7.5 Roche
- 7.5.1 Roche Company Information
- 7.5.2 Roche Business Overview
- 7.5.3 Roche Treatment of PNH Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Roche Treatment of PNH Product Portfolio
- 7.5.5 Roche Recent Developments
- 7.6 Novartis
- 7.6.1 Novartis Company Information
- 7.6.2 Novartis Business Overview
- 7.6.3 Novartis Treatment of PNH Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Novartis Treatment of PNH Product Portfolio
- 7.6.5 Novartis Recent Developments
8 North America
- 8.1 North America Treatment of PNH Market Size by Type
- 8.1.1 North America Treatment of PNH Revenue by Type (2021-2032)
- 8.1.2 North America Treatment of PNH Sales by Type (2021-2032)
- 8.1.3 North America Treatment of PNH Price by Type (2021-2032)
- 8.2 North America Treatment of PNH Market Size by Application
- 8.2.1 North America Treatment of PNH Revenue by Application (2021-2032)
- 8.2.2 North America Treatment of PNH Sales by Application (2021-2032)
- 8.2.3 North America Treatment of PNH Price by Application (2021-2032)
- 8.3 North America Treatment of PNH Market Size by Country
- 8.3.1 North America Treatment of PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Treatment of PNH Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Treatment of PNH Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Treatment of PNH Market Size by Type
- 9.1.1 Europe Treatment of PNH Revenue by Type (2021-2032)
- 9.1.2 Europe Treatment of PNH Sales by Type (2021-2032)
- 9.1.3 Europe Treatment of PNH Price by Type (2021-2032)
- 9.2 Europe Treatment of PNH Market Size by Application
- 9.2.1 Europe Treatment of PNH Revenue by Application (2021-2032)
- 9.2.2 Europe Treatment of PNH Sales by Application (2021-2032)
- 9.2.3 Europe Treatment of PNH Price by Application (2021-2032)
- 9.3 Europe Treatment of PNH Market Size by Country
- 9.3.1 Europe Treatment of PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Treatment of PNH Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Treatment of PNH Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Treatment of PNH Market Size by Type
- 10.1.1 China Treatment of PNH Revenue by Type (2021-2032)
- 10.1.2 China Treatment of PNH Sales by Type (2021-2032)
- 10.1.3 China Treatment of PNH Price by Type (2021-2032)
- 10.2 China Treatment of PNH Market Size by Application
- 10.2.1 China Treatment of PNH Revenue by Application (2021-2032)
- 10.2.2 China Treatment of PNH Sales by Application (2021-2032)
- 10.2.3 China Treatment of PNH Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Treatment of PNH Market Size by Type
- 11.1.1 Asia Treatment of PNH Revenue by Type (2021-2032)
- 11.1.2 Asia Treatment of PNH Sales by Type (2021-2032)
- 11.1.3 Asia Treatment of PNH Price by Type (2021-2032)
- 11.2 Asia Treatment of PNH Market Size by Application
- 11.2.1 Asia Treatment of PNH Revenue by Application (2021-2032)
- 11.2.2 Asia Treatment of PNH Sales by Application (2021-2032)
- 11.2.3 Asia Treatment of PNH Price by Application (2021-2032)
- 11.3 Asia Treatment of PNH Market Size by Country
- 11.3.1 Asia Treatment of PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Treatment of PNH Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Treatment of PNH Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Treatment of PNH Market Size by Type
- 12.1.1 SAMEA Treatment of PNH Revenue by Type (2021-2032)
- 12.1.2 SAMEA Treatment of PNH Sales by Type (2021-2032)
- 12.1.3 SAMEA Treatment of PNH Price by Type (2021-2032)
- 12.2 SAMEA Treatment of PNH Market Size by Application
- 12.2.1 SAMEA Treatment of PNH Revenue by Application (2021-2032)
- 12.2.2 SAMEA Treatment of PNH Sales by Application (2021-2032)
- 12.2.3 SAMEA Treatment of PNH Price by Application (2021-2032)
- 12.3 SAMEA Treatment of PNH Market Size by Country
- 12.3.1 SAMEA Treatment of PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Treatment of PNH Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Treatment of PNH Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Treatment of PNH Value Chain Analysis
- 13.1.1 Treatment of PNH Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Treatment of PNH Production Mode & Process
- 13.2 Treatment of PNH Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Treatment of PNH Distributors
- 13.2.3 Treatment of PNH Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst